Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Enlivex Ltd. - Ordinary Shares (NQ:ENLV)

0.8886 +0.0101 (+1.15%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	389,910
Open	0.8870
Bid (Size)	0.8505 (100)
Ask (Size)	0.8940 (100)
Prev. Close	0.8785
Today's Range	0.8650 - 0.9000
52wk Range	0.6600 - 2.100
Shares Outstanding	18,306,186
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

April 21, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025

March 26, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	+17.7%	+17.7%
1 Month	-19.9%	-19.9%
3 Month	-9.4%	-9.4%
6 Month	-16.2%	-16.2%
1 Year	-0.2%	-0.2%

More News

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt

March 26, 2026

From Enlivex Ltd.

Via GlobeNewswire

Wondering what's happening in today's pre-market session? ↗

March 25, 2026

Via Chartmill

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48

March 25, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program

March 24, 2026

From Enlivex Ltd.

Via GlobeNewswire

Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

March 23, 2026

From Enlivex Ltd.

Via GlobeNewswire

Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

March 20, 2026

Via ACCESS Newswire

Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange

February 10, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance

February 09, 2026

Via ACCESS Newswire

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange

January 26, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

January 23, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange

January 07, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development

December 04, 2025

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement

November 26, 2025

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Kartoon Studios Mainframe Studios, Toon Media, and Premium IP Pipeline Drive 2026-2027 Outlook

November 24, 2025

Via AB Newswire

Which stocks are experiencing notable movement on Monday? ↗

November 24, 2025

Via Chartmill

These stocks are making the most noise in today's session. ↗

November 24, 2025

Via Chartmill

Top movers in Monday's session ↗

November 24, 2025

Via Chartmill

The market is filled with gapping stocks in Monday's session. ↗

November 24, 2025

Via Chartmill

ENLV Stock Surges After Pivot To Crypto-Backed Treasury, Names Former Italian PM To Board ↗

November 24, 2025

Via Stocktwits

Wondering what's happening in today's pre-market session? ↗

November 24, 2025

Via Chartmill

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

November 24, 2025

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis

November 24, 2025

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025

October 28, 2025

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Frequently Asked Questions

Is Enlivex Ltd. - Ordinary Shares publicly traded?

Yes, Enlivex Ltd. - Ordinary Shares is publicly traded.

What exchange does Enlivex Ltd. - Ordinary Shares trade on?

Enlivex Ltd. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Enlivex Ltd. - Ordinary Shares?

The ticker symbol for Enlivex Ltd. - Ordinary Shares is ENLV on the Nasdaq Stock Market

What is the current price of Enlivex Ltd. - Ordinary Shares?

The current price of Enlivex Ltd. - Ordinary Shares is 0.8886

When was Enlivex Ltd. - Ordinary Shares last traded?

The last trade of Enlivex Ltd. - Ordinary Shares was at 04/22/26 04:00 PM ET

What is the market capitalization of Enlivex Ltd. - Ordinary Shares?

The market capitalization of Enlivex Ltd. - Ordinary Shares is 16.27M

How many shares of Enlivex Ltd. - Ordinary Shares are outstanding?

Enlivex Ltd. - Ordinary Shares has 16M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.